DRKS00029567已完成不适用
A non-interventional, prospective, multicenter study to describe patient preference and real-world outcomes of Diroximel Fumarate for the treatment of relapsing remitting multiple sclerosis in daily clinical practice - VIKY-GER Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Biogen GmbH
- 入组人数
- 118
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Established clinical diagnosis of relapsing-remitting MS
- •2. Able to understand the purpose and risks of the study, ability and willingness to follow study procedures, and provide signed and dated study-specific informed consent form (ICF)
- •3. Having been prescribed treatment with Vumerity (DRF) or Tecfidera (DMF) according to label and local market reimbursement criteria and treatment is planned to be initiated within 30 days after enrollment or already initiated, with enrollment occurring no more than 30 days after the first dose.
- •4. Patients aged 18 years or above
排除标准
- •1. Contraindication to dimethyl or diroximel fumarate treatment according to SmPC
- •2. Unable or unwilling to provide informed consent
- •3. Progressive forms of MS
- •4. Have received the newly prescribed treatment with DRF / DMF for more than 30 days
- •5. Have been prescribed another DMF than Tecfidera
研究者
相似试验
进行中（未招募）
4 期
A multi-hospital approach that depicts the routine practice of doctors treating patients with type 2 diabetes with Novomix 30, which will evaluate willingness and ability to pay in a real world population.CTRI/2017/10/010218ovo Nordisk India Private Ltd
招募中
不适用
Prospective, multi-centre, non-interventional study on the use, tolerability and safety of the One Strength dose escalation scheme with NOVo Helisen® hoUSe dust mites in everyday practiceJ30.3J30.4H10.1J45.0Other allergic rhinitisAllergic rhinitis, unspecifiedAcute atopic conjunctivitisPredominantly allergic asthmaDRKS00032532Allergopharma GmbH & Co. KG1,000
招募中
不适用
A prospective, non-interventional, multicenter, observational study to investigate the effectiveness and safety of Sevikar HCT® Tablet in hypertensive patients with type 2 diabetes mellitus or prediabetes in KoreaDiseases of the circulatory systemKCT0006918Daiichi-Sankyo Korea3,000
已完成
不适用
A multicenter, prospective, non-interventional observational study to determine LDL-C goal attainment rate in elderly patients with dyslipidemia receiving Mevalotin® Tab.KCT0003190Daiichi-Sankyo Korea3,000
招募中
不适用
Multicenter, non-interventional, prospective observational study to investigate the local treatment of chemotherapy-induced peripheral neuropathy with QUTENZA in breast cancer patientsG62.0Drug-induced polyneuropathyDRKS00022442Grünenthal GmbH German Sales Division77